Form 4: Aethlon Medical Director Forfeits Shares for Tax Withholding on RSU Conversion

Aethlon Medical Director Edward G. Broenniman forfeited 893 shares of common stock to cover tax withholdings upon the conversion of 4,465 vested restricted stock units.

Summary

• Edward G. Broenniman, a Director of Aethlon Medical Inc. (AEMD), forfeited 893 shares of common stock.
• The forfeiture occurred on June 30, 2025, at a price of $1.2 per share.
• This forfeiture was to cover tax withholdings related to the conversion of an aggregate of 4,465 vested and outstanding restricted stock units (RSUs) into common stock.
• The RSUs were part of a grant previously reported in a Form 4 filed on April 25, 2025.
• Following this transaction, Edward G. Broenniman directly beneficially owns 21,825 shares of Aethlon Medical common stock.

Sentiment

Score: 5

Explanation: The document reports a routine, administrative transaction related to executive compensation (tax withholding on RSU vesting). It does not indicate any positive or negative operational or financial performance, nor does it suggest any strategic shifts. Therefore, the sentiment is neutral.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The Reporting Person forfeited 893 shares of common stock upon conversion of an aggregate 4,465 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture.

Industry Context

This transaction represents a routine insider filing related to executive compensation. The forfeiture of shares to cover tax obligations upon the vesting and conversion of restricted stock units is a common and standard practice across industries for equity-based compensation plans.

Stakeholder Impact

• Shareholders: Minimal direct impact, as this is a routine administrative transaction related to executive compensation and not indicative of operational performance or strategic changes. It slightly reduces the number of shares held by a director.
• Employees: Reflects the standard process for equity compensation, which is a common component of executive and employee remuneration.

Key Dates

Keywords

Aethlon Medical, AEMD, Form 4, Insider Transaction, Stock Forfeiture, Tax Withholding, Restricted Stock Units, Director Compensation